EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudiePragmatische StudieOpen access

Magnesium and Hematoma Expansion in Intracerebral Hemorrhage: A FAST-MAG Randomized Trial Analysis

Eric M Liotta iD, Matthew B Maas iD, Shyam Prabhakaran iD, Kristina Shkirkova iD, Nerses Sanossian iD, David S Liebeskind iD, Latisha Sharma iD, Samuel Stratton iD, Robin Conwit iD, Jeffrey L Saver iD, FAST-MAG Investigators and Coordinators

Stroke · 2024

DOI: 10.1161/strokeaha.123.043555 ↗

At a glance

Randomisierte kontrollierte Studie in Stroke, 2024. Written by Eric M Liotta and 10 co-authors. Institution: Department of Neurology, Northwestern University, Chicago, IL (E.M.L., M.B.M.). Major MEDLINE topics: Stroke, Hemostatics. Cited 8 times so far (Crossref); 6 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS, NINDS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Observational studies suggest that magnesium may have hemostatic effects. FAST-MAG (Field Administration of Stroke Therapy-Magnesium) was a pragmatic clinical trial of magnesium sulfate administered prehospital for acute clinical stroke syndromes and included patients with intracerebral hemorrhage. Exploratory secondary analysis by the treatment group found no reduction in hematoma expansion (HE) associated with magnesium treatment in intracerebral hemorrhage but did not consider serum magnesium levels achieved. We analyzed FAST-MAG intracerebral hemorrhage data for associations between serum magnesium level, HE, and early neurological deterioration, accounting for groupwise biases. METHODS: HE was defined as hematoma volume increase ≥3 mL within 24 hours and early neurological deterioration as ≥1-point Glasgow Coma Scale decline from arrival to hospital day 4. Comparing treatment and placebo groups confirmed biased availability of neuroimaging data. Therefore, HE and neurological deterioration were analyzed and stratified by treatment and placebo groups using univariate tests and adjusted logistic regression. RESULTS: Spontaneous intracerebral hemorrhage was present in 381 patients. Placebo patients had fewer serial neuroimaging studies available (123 [65.4%] versus 145 [75.1%]; P =0.038). Necessary data were available in 104 magnesium- and 85 placebo-treated patients (age, 64.9 [13.0] years; 67.7% male). In the magnesium group, higher magnesium level was associated with less HE (adjusted odds ratio, 0.64 per mg/dL [95% CI, 0.42–0.93]) and less neurological deterioration (adjusted odds ratio, 0.54 per mg/dL [95% CI, 0.33–0.82]). In the placebo group, magnesium level was not associated with either HE or neurological deterioration. CONCLUSIONS: Magnesium may exhibit a hemostatic effect that was only observable in the FAST-MAG magnesium treatment group. Equipoise should be maintained, and specific trials are needed. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00059332.

Subjects

MeSH terms (MEDLINE)

StrokeHemostaticsHumansMaleMiddle AgedAgedFemaleMagnesiumCerebral HemorrhageHematoma

Author keywords

hematomahemorrhagehemorrhagic strokemagnesiumserumstroke

Substances

MagnesiumHemostatics

Authors and institutions

  • Department of Neurology, Northwestern University, Chicago, IL (E.M.L., M.B.M.).
  • Department of Neurology, University of Chicago, IL (S.P.).
  • Department of Neurology, University of California, Los Angeles (K.S., D.S.L., L.S., S.S., J.L.S.).
  • Department of Neurology, University of Southern California, Los Angeles (N.S.).
  • Office of Clinical Research, Division of Extramural Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.C.).
  • Department of Neurology, Indiana University, Indianapolis (R.C.).

ORCID profiles: Eric M Liotta, Matthew B Maas, Shyam Prabhakaran, Kristina Shkirkova, Nerses Sanossian, David S Liebeskind, Latisha Sharma, Samuel Stratton, Robin Conwit, Jeffrey L Saver

Funding

  • NIA NIH HHS
  • NINDS NIH HHS

Cite

APA

Liotta, E. M., Maas, M. B., Prabhakaran, S., Shkirkova, K., Sanossian, N., Liebeskind, D. S., Sharma, L., Stratton, S., Conwit, R., Saver, J. L., & FAST-MAG Investigators and Coordinators (2024). Magnesium and Hematoma Expansion in Intracerebral Hemorrhage: A FAST-MAG Randomized Trial Analysis. Stroke. https://doi.org/10.1161/strokeaha.123.043555

Vancouver

Liotta EM, Maas MB, Prabhakaran S, Shkirkova K, Sanossian N, Liebeskind DS, et al. Magnesium and Hematoma Expansion in Intracerebral Hemorrhage: A FAST-MAG Randomized Trial Analysis. Stroke. 2024. doi:10.1161/strokeaha.123.043555

BibTeX
@article{Liotta2024,
  author = {Liotta, Eric M and Maas, Matthew B and Prabhakaran, Shyam and Shkirkova, Kristina and Sanossian, Nerses and Liebeskind, David S and Sharma, Latisha and Stratton, Samuel and Conwit, Robin and Saver, Jeffrey L and FAST-MAG Investigators and Coordinators, FAST-MAG Investigators and Coordinators},
  title = {Magnesium and Hematoma Expansion in Intracerebral Hemorrhage: A FAST-MAG Randomized Trial Analysis},
  journal = {Stroke},
  year = {2024},
  doi = {10.1161/strokeaha.123.043555}
}
Start for free →